ARGO Vision e SEA Vision insieme per costruire il futuro dell’industria 4.0

 ARGO Vision e SEA Vision insieme per costruire il futuro dell’industria 4.0. Una giovane start-up specializzata nell’applicare le tecniche di deep learning alla visione artificiale ed una azienda esperta in sistemi di visione, tracciabilità e industria 4.0 per il confezionamento dei farmaci: sono questi i due protagonisti di una storia tutta italiana che parla di…

Una nuova generazione di hardware in linea con l’upgrade a Windows 10

SEA Vision: una nuova generazione di hardware in linea con l’upgrade a Windows 10   La Software House pavese progetta e rinnova costantemente i suoi sistemi hardware e software, trasformando l’evoluzione in protagonista a tutti gli effetti. In quest’ottica SEA Vision ha sviluppato una nuova generazione di hardware industrializzati e miniaturizzati, facilmente integrabili sulle macchine…

OEE Data Collection

Pharma tech partners launch new plug-in to improve production efficiency

Serialization software provider SEA Vision and packaging machine manufacturer Marchesini Group have collaborated to launch a new OEE data collection plug-in designed to improve efficiencies during pharmaceutical manufacturing. As pharmaceutical manufacturers across the globe prepare for new serialization requirements for the tracking and tracing of medicines in the supply chain, the new plug-in complements the…

serialization implementation

Research reveals costly implementation the biggest barrier to serialization compliance

According to new industry research, more than half (54%) of industry professionals believe that the cost of implementing serialization is the greatest hurdle to compliance. The research, conducted by serialization software provider, SEA Vision and life sciences technology firm, Zenith Technologies, highlighted that the substantial investment required to implement a serialization solution is cause for…

pharmaceutical serialization compliance

The future of serialization

Pharmaceutical serialization compliance will soon be a reality for every pharmaceutical manufacturer. Regulations are already in place in China, Turkey, South Korea and India to name a few markets, and with the U.S. and the EU soon to follow, time is of the essence. In our final blog in the series, serialization director Carlos Machado…

preparing for serialization

Why you should already be preparing for serialization

Preparing for serialization: why you need to start now Serialization is one of the biggest issues facing the pharmaceutical industry today, and with upcoming deadlines in the U.S., and the EU, it should be a priority for all drug manufacturers. However, new industry research we’ve conducted has revealed that more than one-third of companies are…

Case Study multi-national pharma company

Case study: global serialization project

SEA Vision supports multi-national pharma company with serialization processes across 200 production lines SEA Vision and Zenith Technologies support pharmaceutical companies with the design, installation and integration of serialization technology and processes across manufacturing sites. Multi-site implementation can often be a challenge for companies without dedicated resources in place. In this case study, a combined…

Technology selection barrier serialization

Technology selection identified as biggest hurdle in serialization race for compliance

Technology selection, a barrier to serialization New industry research explores the greatest barriers to serialization success as companies across the pharmaceutical supply chain prepare for new regulations in the US and Europe. The research, conducted by serialization system provider SEA Vision and life science technology specialist Zenith Technologies, highlights technology selection as the biggest challenge…

serialization strategic planning

Ahead of the curve: planning for serialization

Implementing a serialization solution in time for new regulations in the US and Europe is a huge task. Serialization will transform the entire supply chain and requires pharmaceutical manufacturers to invest in new technology, adapt their current processes and systems and ensure staff understands the new regulatory environment in which they are working. With so…

Beyond compliance: serialization across the globe

By 2020 most major markets will have pharmaceutical serialization regulations in place, however it is not a one size fits all scenario with requirements and timelines differing across countries. In the third part of our Serialization Series, Zenith Technologies’ serialization director, Carlos Machado and our senior R&D product manager Matteo Barbieri discuss the different approaches…

pharmaceutical serialization drivers

Safety first: drivers of serialization

PHARMACEUTICAL SERIALIZATION KEY DRIVERS – PART 2 Pharmaceutical serialization drivers have been well discussed, with sales of counterfeit drugs now amounting to $75 billion annually and the overall value of the falsified drugs market estimated at around $200 billion. In this second part (read the first article here) of our Serialization Series, Zenith Technologies’ serialization director,…